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A phase II clinical trial is already underway to approve L-Serine as a 
treatment for  Alzheimer’s Disease. The next step would  be getting 
L-Serine approved for a phase III clinical trial. In addition to AD, L-
Serine has been show to be neuroprotective against other NDs 
such as ALS, and Parkinson’s Disease. If it could be shown that L-
Serine can be used as a neuroprotectant against all of these 
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More than 6 million people in America are living with Alzheimer’s Disease (AD) and 
there are no cures or treatments. It is time to move on from the ꞵ-amyloid hypothesis 
and broaden AD research. New research is suggesting that dietary exposure to a 
cyanobacterial toxin known as L-BMAA is causing neurodegenerative diseases such 
as AD, ALS, and Parkinson’s Disease. L-BMAA is misincorporated during protein 
folding, in place of the proper amino acid, L-Serine.  It has been shown that the 
naturally occurring amino acid, L-Serine, can provide neuroprotection against L-
BMAA, but the mechanism by which L-Serine infers this protection is unclear. This 
thesis will examine how the amino acid L-Serine can be used as a preventative 
measure against L-BMAA-induced Alzheimer’s Disease. Both articles by Dunlop et 
al., 2018 have shown that L-Serine provides neuroprotection by diluting the cell and 
decreasing the probability that L-BMAA is misincorporated, and also by increasing 
the unfolded protein response. In both studies, QPCR and Western Blotting were 
used to study what genes and cellular pathways both L-Serine and L-BMAA 
activated. As more researchers begin to move away from the ꞵ-amyloid hypothesis, 
it is important that we broaden our research horizons and work with other disciplines 
within the scientific community. By studying AD from different angles, a better 
understanding of AD will be gained, potentially offering other therapeutic approaches 
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• Alzheimer’s Disease (AD) was discovered over 100 years 
ago, but we have yet to develop a cure or effective treatment 
(Goedert & Spillantini, 2006).  
• 30 years ago the β-amyloid hypothesis was proposed as a 
mechanism to understand AD, but it has become a dead end 
(Goedert et al., 2006). 
• New research has shown that the cyanobacterial toxin, L-
BMAA, causes neurodegenerative diseases such as AD, 
ALS, and Parkinson’s Disease (Cox et al., 2016). 
• It has been shown that the amino acid L-Serine provides 
neuroprotection against L-BMAA  thus protection against AD 
(Metcalf et al., 2018). 
• The mechansim by which L-BMAA causes 
neurodegeneration is understood, but less is known about 
how L-Serine provides protection (Dunlop  et al., 2018). 
• New research suggests that L-Serine provides 
neuroprotection by elevating the UPR response within cells 
(Dunlop et al., 2018). 
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• L-Serine and L-BMAA modulated numerous amounts of 
the same genes and they follow similar cellular 
pathways (Dunlop et al., 2018). 
• L-Serine increases translation of the ER chaperone 
PDI, which plays an important role in the UPR. 
• PDI helps break down misfolded proteins through 
endoplasmic reticulum-associated degradation (ERAD). 
• By activating ER stress and triggering the UPR, L-
Serine could be priming cells to respond to neurotoxic 
stress pre-emptively.  
• L-Serine could be conferring this protection by acting as 
a proteostasis regulator (PR).  
• As a PR, L-Serine helps cells quickly respond to 
oxidative stress thus favoring a quick return to 
homeostasis.  
• By upregulating the UPR, heat shock genes, and 
transcription factors, L-Serine primes cells to respond 
rapidly when exposed to a neurotoxin.  
 
 
The diagram to 
the left displays 
the process of 
NFT and β-
amyloid plaque 
formation (Cox et 
al., 2016). 
L-BMAA increased expression of ATF4 
when compared to L-Serine, thus 
suggesting L-BMAA activated the PERK 
pathway.  
Cells treated with L-Serine had 
significantly higher levels of PDI 
protein when compared to  controls 
and L-BMAA.  
L-BMAA concentration increases as the toxin is transferred from 
cyanobacteria, to cycad seeds, to flying foxes.  
L-Serine significantly inhibited the incorporation of L-BMAA when compared 
to other treatments.  
